Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Early Versus Delayed Pneumococcal Vaccination in HIV

This study has been completed.
Sponsor:
Collaborator:
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by:
CIHR Canadian HIV Trials Network
ClinicalTrials.gov Identifier:
NCT00137605
First received: August 26, 2005
Last updated: February 11, 2014
Last verified: February 2014